Gastrointestinal dysfunction in Parkinson's disease

RF Pfeiffer - Parkinsonism & related disorders, 2011 - Elsevier
In recent years, an increasingly detailed picture of gastrointestinal dysfunction in the setting
of Parkinson's disease has emerged. Abnormalities of function may occur at virtually all …

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy

WH Jost, H Hefter, A Stenner, G Reichel - Journal of neural transmission, 2013 - Springer
Botulinum neurotoxin is the therapy of choice for all forms of cervical dystonia (CD), but
treatment regimens still vary considerably. The interpretation of treatment outcome is mainly …

Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2

Z Liu, PG Lee, N Krez, K Lam, H Liu… - Nature …, 2023 - nature.com
Abstract Botulinum neurotoxin E (BoNT/E) is one of the major causes of human botulism and
paradoxically also a promising therapeutic agent. Here we determined the co-crystal …

Central origin of the antinociceptive action of botulinum toxin type A

L Bach-Rojecky, Z Lacković - Pharmacology Biochemistry and Behavior, 2009 - Elsevier
Here we provide behavioural evidence for an axonal transport and the central origin of the
antinociceptive effect of botulinum toxin type A (BTX-A). In rats we investigated the …

Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection

L Bach-Rojecky, M Šalković-Petrišić… - European journal of …, 2010 - Elsevier
We investigated antinociceptive activity of botulinum toxin type A (BTX-A) in a model of
diabetic neuropathic pain in rats. Male Wistar rats were made diabetic by a single …

Botulinum toxin type a as a therapeutic agent against headache and related disorders

S Luvisetto, P Gazerani, C Cianchetti, F Pavone - Toxins, 2015 - mdpi.com
Botulinum neurotoxin A (BoNT/A) is a toxin produced by the naturally-occurring Clostridium
botulinum that causes botulism. The potential of BoNT/A as a useful medical intervention …

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm

C Kenney, J Jankovic - Journal of neural transmission, 2008 - Springer
Blepharospasm and hemifacial spasm are the two most common craniofacial movement
disorders. Blepharospasm is a syndrome characterized by excessive or continuous eye …

Applications of botulinum toxin in dentistry: A comprehensive review

S Srivastava, S Kharbanda, US Pal… - National journal of …, 2015 - journals.lww.com
The horizons of treatment options in dentistry are broadening rapidly. In this scenario,
applications of unconventional treatment options like use of botulinum toxin (BT) are gaining …

Clinical use of botulinum toxins in oral and maxillofacial surgery

OW Majid - International journal of oral and maxillofacial surgery, 2010 - Elsevier
Botulinum toxin (BTX) is a bacterial toxin that could be used as a medicine. Clinical
applications of BTX have been expanding over the last 30 years and novel applications …

Temporomandibular joint dislocation

NK Sharma, AK Singh, A Pandey… - National journal of …, 2015 - journals.lww.com
Temporomandibular joint (TMJ) dislocation is an uncommon but debilitating condition of the
facial skeleton. The condition may be acute or chronic. Acute TMJ dislocation is common in …